We are live on
!
Find out more
IC
Investment Counsel Portfolio holdings
AUM
$142M
1-Year Est. Return
36.99%
This Fund
S&P 500
This Quarter
Est. Return
+3.72%
1 Year Est. Return
+36.99%
3 Year Est. Return
+50.09%
5 Year Est. Return
+81.67%
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$16.6M
(+15%)
Cap. Flow
+$13.3M
Cap. Flow
% of AUM
10.73%
Top 10 Holdings %
Top 10 Hldgs %
41.31%
Holding
68
New
6
Increased
33
Reduced
23
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$6.33M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.69M |
| 3 |
GE Aerospace
GE
|
+$667K |
| 4 |
Home Depot
HD
|
+$644K |
| 5 |
Merck
MRK
|
+$598K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$1.5M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.21M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$269K |
| 4 |
Honeywell
HON
|
+$183K |
| 5 |
AT&T
T
|
+$162K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.38% |
| 2 | Consumer Staples | 13.16% |
| 3 | Technology | 10.75% |
| 4 | Industrials | 8.49% |
| 5 | Consumer Discretionary | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Verizon
VZ
$195B
| $532K | 0.43% |
9,522
| – | – |
|
52
Vertex Pharmaceuticals
VRTX
$121B
| $516K | 0.42% |
+6,000
| New | +$518K |
|
53
Amgen
AMGN
$208B
| $509K | 0.41% |
+3,348
| New | +$521K |
|
|
WFM
54
DELISTED
Whole Foods Market Inc
WFM
| $499K | 0.4% |
15,579
-3,001
| -16% | -$93.3K |
|
55
Novartis
NVS
$297B
| $470K | 0.38% |
+6,361
| New | +$439K |
|
|
TIF
56
DELISTED
Tiffany & Co.
TIF
| $432K | 0.35% |
7,124
-800
| -10% | -$53.2K |
|
|
LLL
57
DELISTED
L3 Technologies, Inc.
LLL
| $397K | 0.32% |
2,703
+99
| +4% | +$13.3K |
|
58
Alphabet (Google) Class A
GOOGL
$4.36T
| $376K | 0.3% |
10,680
-2,000
| -16% | -$73.4K |
|
59
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| $337K | 0.27% |
+9,800
| New | +$329K |
|
60
Entergy
ETR
$50.2B
| $329K | 0.27% |
8,080
| – | – |
|
61
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $296K | 0.24% |
2,760
-25
| -0.9% | -$2.65K |
|
62
Sony
SONY
$137B
| $294K | 0.24% |
+50,000
| New | +$268K |
|
63
AbbVie
ABBV
$443B
| $248K | 0.2% |
+4,000
| New | +$244K |
|
64
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $230K | 0.19% |
7,700
-1,500
| -16% | -$44K |
|
|
65
Honeywell
HON
$77B
| $215K | 0.17% |
2,059
-1,780
| -46% | -$183K |
|
66
Duke Energy
DUK
$97.8B
| $207K | 0.17% |
2,417
-840
| -26% | -$67.1K |
|
|
67
iShares MSCI EAFE ETF
EFA
$78B
| – | – |
-4,700
| Closed | -$269K |
|
|
68
iShares Core S&P 500 ETF
IVV
$872B
| – | – |
-5,865
| Closed | -$1.21M |
|
Similar funds
DGHMC
BP
FLSMF
CIA
WU
EH
IWAG
UBPAM
Investment Counsel's Q2 2016 Portfolio in Review
As of Q2 2016, Investment Counsel held 68 positions worth $124M, up 15% from $107M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Investment Counsel deployed $13.3M of net new capital in Q2 2016, opening 6 new positions and adding to 33 existing holdings. Its largest new stake was Amgen: 3,348 shares worth $509K.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 13% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $1.5M trimmed.
- Investment Counsel's largest Q2 2016 buy was Amgen: 3,348 shares worth $509K.
- Investment Counsel added most to Medtronic in Q2 2016, an estimated $6.33M increase.
- Investment Counsel's biggest Q2 2016 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $1.5M.
- Investment Counsel fully exited iShares Core S&P 500 ETF in Q2 2016, selling an estimated $1.21M.
- Investment Counsel's ten largest holdings make up 41% of its $124M portfolio in Q2 2016.
- Investment Counsel opened 6 new positions and closed 2 in Q2 2016.
- Investment Counsel's portfolio value rose 15% quarter-over-quarter to $124M.
Based on Investment Counsel's 13F filing for Q2 2016, filed 18 Jul 2016.